<DOC>
	<DOC>NCT02035267</DOC>
	<brief_summary>The objectives of this study are to explore the safety and efficacy of subcutaneous injections of ATX-101 relative to placebo, in the submental area.</brief_summary>
	<brief_title>Safety Study of ATX-101 in Subjects With Varying Chin Sizes</brief_title>
	<detailed_description />
	<mesh_term>Deoxycholic Acid</mesh_term>
	<criteria>Male and female subjects, 18 to 65 years old Stable Body weight BMI of ≤40.0 kg/m2 Acceptable volume of submental fat graded by clinician Dissatisfaction with the submental area expressed by the subject Signed informed consent form (ICF) No prior intervention for SMF (eg, liposuction, surgery, or lipolytic agents) Absence of clinically significant health problems History of any intervention to treat SMF (eg, liposuction, surgery, or lipolytic agents) History of trauma associated with the chin or neck areas that in the judgment of the investigator may affect evaluation of safety or efficacy of treatment Body mass index ≤40 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>